Neurofibromatosis Type 2

Explore clinical trials studying Neurofibromatosis Type 2. Study availability and eligibility vary by location and protocol.

15 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Neurofibromatosis Type 2 trial results

Completed

NCT02246231

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +25 more
Locations: Central Manchester University Hospitals NHS Foundation Trust Manchester, Manchester (Manchester Borough), United Kingdom

Completed

NCT01207687

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +29 more
Locations: Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

National Cancer Institute Rockville, Maryland, United States

Massachusetts General Hospital Charlestown, Massachusetts, United States

Completed

NCT03210285

Conditions: Acoustic Neuroma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +30 more
Locations: University Department of Neurosurgery Tübingen Tübingen, Germany

Completed

NCT02104323

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +29 more
Locations: Beijing Tiantan Hospital Affiliated to Capital Medical University Beijing, Beijing Municipality, China

Terminated

NCT05130866

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +25 more
Locations: House Institute Los Angeles, California, United States

University of California Los Angeles Los Angeles, California, United States

Children's National Hospital Washington D.C., District of Columbia, United States

University of Florida Gainesville, Florida, United States

View all 15 locations